Studying lung immune cells and gut microbes in ARDS
Part of Lungs & breathing clinical trials.
This trial studies how immune cells in the lungs and gut microbes (your microbiome) change during ARDS and how these changes relate to your outcomes. It may help researchers better predict and treat ARDS by learning what’s going on in the lungs and body systems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently admitted to the ICU at Hvidovre Hospital
- You were intubated (breathing tube placed) within the last 72 hours
- You have ARDS that is moderate-to-severe or none-to-mild based on a standard definition
- Your ARDS is not caused by COVID-19
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how immune cells in the lungs relate to the microbiome (the helpful microbes in the gut) in healthy adults. It may help scientists understand what affects lung health and immune balance.
This study collects health information from ICU patients with or at high risk for ARDS to better understand the condition and develop a tool to help doctors make decisions. It may not directly help you, but it could improve care for future patients.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This study looks at how the immune system responds in people with ARDS (a severe lung injury) and tests a new treatment called PIP-2 in the lab to see if it might help. It aims to better understand lung injury and find new ways to treat it.
This trial tests a new way of setting the breathing machine for people with a lung condition called ARDS. It may help improve breathing and recovery compared to standard care.
This study looks at blood and sputum samples from people with ARDS (a serious lung condition) to find clues that might predict how well they will recover. The goal is to improve care and outcomes for future patients.
Hear when a new ARDS, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.